Clinical trials
Hereditary Sensory and Autonomic Neuropathies trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Novartis Pharmaceuticals | 3 |
| EMD Serono Research & Development Institute, Inc. | 2 |
| AbbVie | 1 |
| Eli Lilly and Company | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hereditary Sensory and Autonomic Neuropathies | 12 |
| Breast Neoplasms | 4 |
| Endometrial Neoplasms | 2 |
| Ovarian Neoplasms | 2 |
| Uterine Cervical Neoplasms | 2 |
| Angiomyolipoma | 1 |
| Astrocytoma | 1 |
| Brain Neoplasms | 1 |
| Breast Diseases | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 51 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.